RedHawk Holdings Corp.

RedHawk Holdings Corp. specializes in the distribution and sale of medical devices and branded generic pharmaceutical drugs, primarily serving markets in the United States and the United Kingdom. The company's diverse operations are organized into three main segments: Land & Hospitality, Medical Device and Pharmaceutical, and Other Services. Within its medical device portfolio, RedHawk manufactures and markets Sharps and Needle Destruction Devices (SNDD), carotid artery digital non-contact thermometers, and the Centri Controlled Entry System, a full-body X-ray scanner. It also acts as a distributor for various medical products, including WoundClot for bleeding control, Berrcom JXB178 infrared non-contact thermometers, and Zonis. Furthermore, the company provides a comprehensive selection of personal protective equipment (PPE), such as Level 1 single-use disposable masks, three-layer Level 3 cotton masks, KN95 and N95 masks, anti-fog and anti-static splash protection face shields, and a range of ultraviolet sanitation lights, including both tabletop and handheld models. Its pharmaceutical offerings encompass branded generic drugs like Paracetamol, Glipizide, and Omeprazole. RedHawk's extensive client base includes retail pharmacies, hospitals, physicians' offices, both private and public healthcare clinics, corrections facilities, educational institutions, veterinary clinics, emergency services, first responders, municipalities, and long-term care facilities. Beyond these core activities, the company also engages in commercial and residential property investment and leasing, the sale of point-of-entry full-body security systems, and the provision of specialized financial services. Originally incorporated in 2005 as Independence Energy Corp., the company rebranded to RedHawk Holdings Corp. in October 2015 and is headquartered in Lafayette, Louisiana.